SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Pediatric pharmacokinetics of the antibiotics in the access and watch groups of the 2019 WHO model list of essential medicines for children: a systematic review

Rashed, AN; Jackson, C; Gastine, S; Hsia, Y; Bielicki, J; Standing, JK; Tomlin, S; Sharland, M (2019) Pediatric pharmacokinetics of the antibiotics in the access and watch groups of the 2019 WHO model list of essential medicines for children: a systematic review. Expert Review of Clinical Pharmacology, 12 (12). pp. 1099-1106. ISSN 1751-2433 https://doi.org/10.1080/17512433.2019.1693257
SGUL Authors: Hsia, Yingfen

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (146kB)
[img] Microsoft Excel (Supplementary table 2) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (72kB)

Abstract

Introduction: Pharmacokinetic-pharmacodynamic (PK-PD) studies of antibiotics in pediatrics are limited. Pediatric dosing regimens for many antimicrobial drugs have been historically derived from adult pharmacokinetic data. Most pediatric formularies and dosing guidelines globally are expert-based and provide no rationale for the recommended doses, leading to heterogeneous guidance. Areas covered: We systematically reviewed the current dosing for 28 antibiotics listed in the Access and Watch groups of the 2019 World Health Organization (WHO) Essential Medicines List for children (EMLc). PubMed and EMBASE were searched for all PK-PD and pharmacological studies in pediatrics up to May 2018. In total, 262 pediatric related articles were deemed eligible. The most studied drugs were those where therapeutic drug monitoring is routine (aminoglycosides, glycopeptides) and study reporting detail was variable, with only 60.0% using the PK-PD results in make dosing recommendations. Based on this evidence, dose recommendations for each antibiotic were made. Expert opinion: We provide an up-to-date review of the limited available evidence on pediatric dosing for the 28 commonly prescribed antibiotics in the 2019 WHO EMLc. We propose synthesized dosing recommendations for those antibiotics administered systemically for the treatment of serious infections. Further PK-PD studies in children, particularly with underlying conditions, are needed.

Item Type: Article
Additional Information: This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Clinical Pharmacology on 25/11/2019, available online: http://www.tandfonline.com/10.1080/17512433.2019.1693257
Keywords: 1115 Pharmacology And Pharmaceutical Sciences, Pharmacology & Pharmacy
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Expert Review of Clinical Pharmacology
ISSN: 1751-2433
Dates:
DateEvent
25 November 2019Published
12 November 2019Accepted
Publisher License: Publisher's own licence
Projects:
Project IDFunderFunder ID
UNSPECIFIEDWorld Health Organizationhttp://dx.doi.org/10.13039/100004423
URI: https://openaccess.sgul.ac.uk/id/eprint/111411
Publisher's version: https://doi.org/10.1080/17512433.2019.1693257

Actions (login required)

Edit Item Edit Item